Title: Peanut allergy burden survey: Factors associated with health‐related quality of life in adolescents

Journal Article · · Clinical and Translational Allergy
DOI: https://doi.org/10.1002/clt2.12234 · OSTI ID:1963540
 [1];  [2];  [3];  [4];  [5]
  1. Allergy Partners P.A. Asheville North Carolina USA
  2. NYU Grossman School of Medicine Hassenfeld Children's Hospital New York New York USA, Department of Pediatrics, Gastroenterology and Nutrition Collegium Medicum University of Warmia and Mazury Olsztyn Poland
  3. H. E. Outcomes LLC Simi Valley Los Angeles California USA
  4. Xcenda LLC Carrolton Texas USA
  5. Aimmune Therapeutics A Nestlé Health Science Company Brisbane California USA

Abstract Background Patients with peanut allergy (PA) experience significant burden of illness, which impacts health‐related quality of life (HRQoL), particularly in adolescence. There is a paucity of research evaluating drivers of HRQoL scores. Methods A prospective, online survey of adolescents with self‐reported, provider‐diagnosed PA completed from November 2018 to January 2019 was used to explore drivers of the real‐world impact of PA on HRQoL using the Pediatric Quality of Life Inventory 4.0 (PedsQL) and other measures. Univariate and multivariate analyses were used to identify potential factors associated with PedsQL scores and to understand the level of association. Results A total of 102 adolescents were included. The final model included 10 variables: race, reported strict peanut avoidance, satisfaction with prophylaxis, moderate‐to‐severe reaction within the past 12 months, touching peanut as cause of most severe reaction, fear of reaction, age, gender, comorbidities, and daily life limitations. In total, three items were shown to be strong predictors of the PedsQL total score including cause of severe reaction was touching peanut (yes), level of agreement with avoiding peanut (completely agree), and satisfaction with prophylaxis (not very much/not at all). Conclusions There is substantial heterogeneity in the impact of the burden of PA on PedsQL scores across patients. This indicates the importance of shared and individualized decision making for PA management to optimize outcomes and improve HRQoL.

Sponsoring Organization:
USDOE
OSTI ID:
1963540
Journal Information:
Clinical and Translational Allergy, Journal Name: Clinical and Translational Allergy Journal Issue: 3 Vol. 13; ISSN 2045-7022
Publisher:
Wiley Blackwell (John Wiley & Sons)Copyright Statement
Country of Publication:
Country unknown/Code not available
Language:
English

References (14)

Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity journal November 2017
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy journal March 2019
Development of a questionnaire to measure quality of life in adolescents with food allergy: the FAQL-teen journal November 2010
Effect of oral immunotherapy to peanut on food-specific quality of life journal November 2012
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results journal October 2020
Has the Prevalence of Peanut Allergy Changed Following Earlier Introduction of Peanut? The EarlyNuts Study journal February 2021
Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials journal June 2022
Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies journal January 2021
Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–Sponsored Expert Panel journal January 2017
The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers journal February 2021
The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity journal March 2021
The global burden of illness of peanut allergy: A comprehensive literature review journal January 2021
APPEAL‐2: A pan‐European qualitative study to explore the burden of peanut‐allergic children, teenagers and their caregivers journal September 2020
Peanut Allergy in Children journal June 2011